![Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS | Neurology Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS | Neurology](https://n.neurology.org/sites/default/files/highwire/neurology/100/23.cover-source.jpg)
Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS | Neurology
![Clinical Trials - analysis End-points, planned and unplanned secondary analyses, interim analyses, stopping rules Dick Menzies, MD Respiratory Epidemiology. - ppt download Clinical Trials - analysis End-points, planned and unplanned secondary analyses, interim analyses, stopping rules Dick Menzies, MD Respiratory Epidemiology. - ppt download](https://images.slideplayer.com/27/9010897/slides/slide_2.jpg)
Clinical Trials - analysis End-points, planned and unplanned secondary analyses, interim analyses, stopping rules Dick Menzies, MD Respiratory Epidemiology. - ppt download
Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease | PLOS Medicine
![The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias | BMC Medical Research Methodology | Full Text The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2288-8-12/MediaObjects/12874_2007_Article_248_Fig1_HTML.jpg)
The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias | BMC Medical Research Methodology | Full Text
![The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-33192-1/MediaObjects/41467_2022_33192_Fig1_HTML.png)
The design and evaluation of hybrid controlled trials that leverage external data and randomization | Nature Communications
![PPT – Interim Analysis of Clinical Trial Liying XU CCTER, CUHK PowerPoint presentation | free to download - id: 3c7e9a-ZjcxY PPT – Interim Analysis of Clinical Trial Liying XU CCTER, CUHK PowerPoint presentation | free to download - id: 3c7e9a-ZjcxY](https://s3.amazonaws.com/images.powershow.com/3964570.pr.jpg)
PPT – Interim Analysis of Clinical Trial Liying XU CCTER, CUHK PowerPoint presentation | free to download - id: 3c7e9a-ZjcxY
![Frontiers | Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers Frontiers | Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers](https://www.frontiersin.org/files/Articles/636561/fonc-11-636561-HTML/image_m/fonc-11-636561-g001.jpg)